Aligos stockholders reelect two Class III directors, approve ESPP amendment adding 500K shares

Aligos Therapeutics, Inc.

Bridget Martell and Carole Nuechterlein elected as Class III directors with 2,092,164 and 2,086,481 votes for, respectively.
Stockholders approved ESPP amendment increasing share reserve by 500,000 shares to 694,714 total, and eliminating evergreen provision.
Ratification of Ernst & Young as auditor for fiscal 2026 approved with 3,786,255 votes for.
Non-binding advisory say-on-pay approved with 2,074,434 votes for; company will hold future advisory votes annually.
Stockholders voted 2,077,884 for annual frequency of say-on-pay; board adopts annual vote until next advisory vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.